Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage

SUMMARY: Osteoporosis, a chronic disease, requires long-term therapy. In Medicare-insured women, denosumab persistence was higher than oral bisphosphonate persistence over up to 3 years of follow-up. Longer-term persistence was higher among women who persisted in the first year of therapy. INTRODUCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, A.J., Liu, J., Yan, H., Stad, R.K., Gandra, S.R., Yehoshua, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608759/
https://www.ncbi.nlm.nih.gov/pubmed/34095966
http://dx.doi.org/10.1007/s00198-021-05951-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608759/
https://www.ncbi.nlm.nih.gov/pubmed/34095966
http://dx.doi.org/10.1007/s00198-021-05951-1

Ejemplares similares